Cited by 29Spondyloarthritis Studies and TreatmentsSleep and related disordersObstructive Sleep Apnea Research

Evaluation of sleep quality in patients with ankylosing spondylitis and efficacy of anti‐TNF‐α therapy on sleep problems: A polisomnographic study

Karatas, Gulsah, Bal, Ajda, Yuceege, Melike, Firat, Hikmet, Gurcay, Eda, Ardic, Sadik, Cakci, Fatma Aytul·2018·International Journal of Rheumatic Diseases

Abstract

Introduction: This study was conducted to investigate the relationship between sleep quality (SQ) and disease activity (DA) in patients with ankylosing spondylitis (AS) and to evaluate the response to anti‐tumor necrosis factor α (anti‐TNF‐α) therapy on sleep disorders. Materials and Methods: A total of 34 patients who met the modified New York classification criteria for AS were included in this prospective study. Patients were divided into two groups as follows: Group I (n = 15) with high DA and receiving anti‐TNF‐α therapy, and Group II (n = 19) in remission. DA was assessed by the Bath AS Disease Activity Index. Pittsburgh Sleep Quality Index (PSQI) and polysomnography (PSG) were used to determine disorders and patterns of sleep, respectively, in both groups at baseline as well as at the third month of anti‐TNF‐α therapy in Group I. Results: Baseline evaluation revealed impaired SQ in 57.9% of all patients. PSG demonstrated obstructive sleep apnea syndrome, snoring and periodic leg movements in 73.7%, 74.4% and 26.3% of patients, respectively. Prior to anti‐TNF‐α therapy, PSQI and snoring score were significantly higher in Group I (P = 0.0001, P = 0.012, respectively). Although there was a significant reduction in PSQI scores in Group I (P = 0.005) at the third month of anti‐TNF‐α therapy, no change was observed in PSG parameters (P > 0.05). Conclusion: Sleep disorders increase in AS, particularly in patients with high DA. Anti‐TNF‐α therapy has improved SQ without any improvement in PSG. Therefore, it may be concluded that PSG parameters might be more associated with disease pathogenesis rather than DA in patients with AS.

Integrity signals

Registry

Crossref · 10.1111/1756-185x.13102

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Anti-TNF therapy in RA patients with high disease activity improves self-reported sleep quality without affecting PSG-derived sleep parameters.

    “In contrast, treatment with anti-TNF therapy in RA patients with high disease activity resulted in an improvement of self-reported sleep quality, without affecting PSG-derived sleep parameters (283).”

    From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [283]

  • Treatment of RA patients with IL-6 or TNF blockers improved sleep.

    “As described in section IID2, treatment of RA patients with IL-6 or TNF blockers improved sleep (196, 283, 535).”

    From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [283]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Karatas, G., Bal, A., Yuceege, M., Firat, H., Gurcay, E., Ardic, S., & Cakci, F. A.
Affiliations
  • Department of Physical Medicine and Rehabilitation Karabuk University Faculty of Medicine Karabuk Turkey
  • Department of Physical Medicine and Rehabilitation Diskapi Education and Research Hospital Ankara Turkey
  • Department of Respiratory Medicine and Sleep Clinic Diskapi Education and Research Hospital Ankara Turkey
Venue
International Journal of Rheumatic Diseases
Publisher
Wiley
Published
2017-05-29
Volume
21
Issue
6
Pages
1263-1269
ISSN
  • 1756-1841 (ISSN-L)
  • 1756-185X
OpenAlex
W2618399580
Cited by
29
References
38
Citations by year
2026: 6 · 2025: 5 · 2023: 6 · 2022: 1 · 2021: 4 · 2019: 6 · 2018: 1
FWCI
1.67
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Rheumatic Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
Keywords
ankylosing spondylitis, sleep quality, sleep disorders, anti-TNF therapy, disease activity, obstructive sleep apnea, snoring, periodic limb movements, polysomnography, Pittsburgh Sleep Quality Index, Bath AS Disease Activity Index
MeSH terms
Adult, Biological Products, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Surveys and Questionnaires, Remission Induction, Severity of Illness Index, Sleep, Sleep Wake Disorders, Spondylitis, Ankylosing, Time Factors, Tumor Necrosis Factor-alpha, Treatment Outcome, Polysomnography, Antirheumatic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review